This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Novo Nordisk A/S
Drug Names(s): Insulin 287, LAI287, NNC0148-0000-0287, ultra-long-acting basal insulin analog
Description: LAI287 is an ultra-long-acting basal insulin analog.
Pink Sheet What’s Yet To Come From Insulin Pipeline
Additional information available to subscribers only: